Results 151 to 160 of about 2,602 (175)

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

open access: yesCost Eff Resour Alloc
Jafari M   +6 more
europepmc   +1 more source

Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response. [PDF]

open access: yesSci Rep
Chida T   +12 more
europepmc   +1 more source

From the Editor's Desk [PDF]

open access: yes, 2015
Bataller, R   +4 more
core  

New drugs: Asunaprevir [PDF]

open access: yesAustralian Prescriber, 2015
openaire   +1 more source

Impact of viral eradication by direct-acting antivirals on clinical outcomes after curative treatment for hepatitis C virus-associated hepatocellular carcinoma. [PDF]

open access: yesTher Adv Gastroenterol
Nagaoki Y   +12 more
europepmc   +1 more source

The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data. [PDF]

open access: yesPharmgenomics Pers Med
Wittwer NL   +6 more
europepmc   +1 more source

The Rise of Fine-Tuned CAR-Based Therapies Against Acute Myeloid Leukemia. [PDF]

open access: yesCancers (Basel)
Segura Tudela A   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy